A publicly traded health care solutions company acquired a specialty pharmaceutical company for $225 million. Our firm advised the health care solutions company on the transaction.
A publicly traded health care solutions company acquired a specialty pharmaceutical company for $225 million. Our firm advised the health care solutions company on the transaction.